Iron A pathological mediator of Alzheimer disease?

Agro Food Industry Hi-Tech

Volumn 19, Issue 6, 2008, Pages 33-36

  Rolston, Raj K ^a   Perry, George ^a,b   Zhu, Xiongwei ^a   Castellani, Rudy J ^c   Dwyer, Barney E ^d,e   Lee, Hyoung Gon ^a   Petersen, Robert B ^a   Smith, Mark A ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University of San Antonio   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d VA MEDICAL CENTER   (United States)

^e DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; CELLULAR INJURY; METAL-BINDING SITES; METAL-CATALYZED OXIDATIONS; NEURONAL POPULATIONS; RADICAL FORMATION; REDOX-ACTIVE METALS; THERAPEUTIC MODALITY;

FREE RADICALS; METALS; NEURONS; NUCLEIC ACIDS; REDOX REACTIONS;

NEURODEGENERATIVE DISEASES;

EID: 59649091470     PISSN: 17226996     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. L.M. Sayre, M.A. Smith et al., Curr Med Chem., 8, pp 721-738 (2001)
2. J.K. Andersen, Nat Med., 10 Suppl, S18-25 (2004).
3. M.A. Smith, S. Taneda et al., Proc Natl Acad Sci U S A. 91, pp. 5710-5714 (1994).
4. P.F. Good, P. Werner et al., Am J Pathol., 149, pp. 21-28 (1996).
5. M.A. Smith, G. Perry et al., Nature, 382, pp. 120-121 (1996).
6. M.A. Smith, P.L. Richey Harris et al., J Neurosci., 17, pp. 2653-2657 (1997).
7. L.M. Sayre, D.A. Zelasko et al., J Neurochem., 68, pp. 2092-2097 (1997).
8. P. Mecocci, U. MacGarvey et al., Ann Neurol., 36, pp. 747-751 (1994).
9. A. Nunomura, G. Perry et al., J Neurosci., 19, pp. 1959-1964 (1999).
10. A. Nunomura, G. Perry et al., J Neuropathol Exp Neurol., 59, pp. 1011-1017 (2000).
11. A. Nunomura, G. Perry et al., J Neuropathol Exp Neurol., 60. pp. 759-767 (2001).
12. G. Perry, R.J. Castellani et al., J Alzheimers Dis., 1, pp. 45-55 (1998).
13. M.A. Smith, P.L. Harris et al., Proc Natl Acad Sci U S A, 94, pp. 9866-9868 (1997).
14. L.M. Sayre, P.I. Moreira et al., Ann Ist Super Sanita, 41, pp. 143-164 (2005).
15. T. Moos, J Comp Neurol., 375, pp. 675-692 (1996).
16. T. Kawamata, I. Tooyama et al., Am J Pathol., 142, pp 1574-1585 (1993).
17. K. Honda, P.I. Moreira et al., Lett Drug Des Discov., 2, pp. 479-482 (2005).
18. Z.M. Qian, Q. Wang, Brain Res Brain Res Rev., 27, pp. 257-267 (1998).
19. K. Pantopoulos, Ann N Y Acad Sci., 1012, pp. 1-13 (2004).
20. J. Dong, C.S. Atwood et al., Biochemistry (Mosc), 42, pp 2768-2773 (2003).
21. L.M. Sayre, G. Perry et al., J Neurochem, 74, pp. 270-279 (2000).
22. R.J. Castellani, P.L. Harris et al., Antioxid Redox Signal., 2, pp. 137-142 (2000).
23. M.A. Smith, K. Wehr et al., Brain Res, 788, pp. 232-236 (1998).
24. M.A. Smith, A. Nunomura et al., Antioxid Redox Signal, 2, pp. 413-420 (2000).
25. M.A. Lovell, J.D. Robertson et al., J Neurol Sci., 158, pp. 47-52 (1998).
26. R.J. Castellani, P.I. Moreira et al., Neurochem Res., 32. pp. 1640-1645 (2007).
27. C.A. Rottkamp, A.K. Raina et al., Free Radic Biol Med., 30, pp. 447-450 (2001).
28. T. Yoshlda, M. Tanaka et al., Neuroreport, 9, pp. 1929-1933 (1998).
29. G. Casadesus, M.A. Smith et al., J Alzheimers Dis., 6, pp. 165-169 (2004).
30. M.A. Smith, R.K. Kutty et al., Am J Pathol., 145, pp. 42-47 (1994)